NASDAQ · GRCE

Grace Therapeutics, Inc.

Closing price · Nov 13, 2026 $1.81

Last insider buy price $2.14 Paid by CEO, Director Prashant Kohli on Sep 9, 2026 (Form 4). Not today's price.

Latest quarter · ended Sep 30, 2026

Cash got weaker

descriptionFiled Nov 12, 2026

Cash from operationsBetter

−$1.78M

Dec '24Sep '26

vs. −$3.14M a year ago

Share countDiluting

+48.9%

Dec '24Sep '26

21.04M shares vs. 14.13M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 13 Funds: as of Jun 30, 2026

account_balance
1 fund bought, 1 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
info
No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

34 funds report owning GRCE, same as the quarter before

Holdings as of Jun 30, 2026

New11

Added12

Held9

Trimmed2

Sold out11

Last quarter

Who bought and who sold

Apr–Jun 2026

Eversept Partners, LP

+2%

Nantahala Capital Management, LLC

Sold

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale

Last 6 months. A wider screen shows 12.

Showing 1 real trade. Bigger dot means a bigger trade.

Real trades, newest first

Sep 9 Prashant Kohli CEO, Director Open-market buy $214K 100,000 sh at $2.14

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in GRCE

As of Jun 30, 2026

Fund	Owns	Value	Change
Cerity Partners LLC	4.0%	$1.93M	Same
Eversept Partners, LP	3.7%	$1.75M	+2%
Bank of America Corp	2.4%	$1.12M	Same
Vanguard Capital Management LLC	2.0%	$935K	+3%
Citadel Advisors LLC	1.7%	$794K	+254%

"Owns" is shares reported divided by shares outstanding.